Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Neuroblastoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Melanoma 1Hepatoblastoma 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Docetaxel 7Radiotherapy 6Filgrastim 6Cisplatin 4Peripheral Blood Stem Cell Transplantation 3Chemotherapy, Adjuvant 3Carboplatin 3selpercatinib 2sargramostim 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Nivolumab 2Gemcitabine 2Etoposide 2Drug Therapy 2Doxorubicin 2Capecitabine 2Biopsy 2Acupuncture Therapy 2vocimagene amiretrorepvec 1vandetanib 1ulixertinib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1spartalizumab 1pentetreotide 1pazopanib 1oncogene protein E7, Human papillomavirus type 16 1oblimersen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × MLN 8237 × CNS × Clear all
NCT01639911 2019-07-22

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

University of Illinois at Chicago

Phase 1 Completed
28 enrolled
BreastCNSDermatologicGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Melanoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡